Use of purified sdg as a hypotensive (vasodilator) agent

Details Use of purified sdg as a hypotensive (vasodilator) agent Use of purified sdg as a hypotensive (vasodilator) agent

A - Human Necessities

61

K

A61K 31/70 (2006.01) A61P 9/00 (2006.01)

Patent

CA 2311606

The compound secoisolariciresinol diglucoside (SDG), obtained from flaxseed is used for treating hypertension or for reducing or preventing the development of elevated blood pressure in humans or animals. These uses include the treatment of ischemic heart disease, heart failure and intermittent claudication.

Le sécoisolaricirésinol diglucoside (SDG) composé, obtenu à partir de la graine de lin, est utilisé pour traiter l'hypertension ou pour réduire ou prévenir le développement de pression sanguine élevée chez les humains ou les animaux. Ces utilisations comprennent le traitement de cardiopathie ischémique, d'insuffisance cardiaque et de claudication intermittente.

Affiliated with

Also associated with

Rating

Use of purified sdg as a hypotensive (vasodilator) agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of purified sdg as a hypotensive (vasodilator) agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of purified sdg as a hypotensive (vasodilator) agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1439850